Granulosa cellandoocyte mitochondrial abnormalities in a mouse model of fragile X primary ovarian insufficiency

Molecular Human Reproduction

Volumn 22, Issue 6, 2016, Pages 384-396

  Dioguardi, Carola Conca ^a,b   Uslu, Bahar ^a   Haynes, Monique ^a   Kurus, Meltem ^c   Gul, Mehmet ^d   Miao, De Qiang ^a   De Santis, Lucia ^b   Ferrari, Maurizio ^b   Bellone, Stefania ^a   Santin, Alessandro ^a   Giulivi, Cecilia ^e   Hoffman, Gloria ^f   Usdin, Karen ^g   Johnson, Joshua ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c IZMIR KATIP CELEBI UNIVERSITY   (Turkey)

^d INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f MORGAN STATE UNIVERSITY   (United States)

^g NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Atresia; Fertility; Follicle; Fragile X premutation; Fragile X primary ovarian insufficiency; Mitochondria; Oocyte; Ovary

Indexed keywords

BETA ACTIN; CYCLOOXYGENASE 1; DYNAMIN I; HEMOGLOBIN BETA CHAIN; MITOFUSIN 1; MITOFUSIN 2; OPTIC ATROPHY 1 PROTEIN; PEROXIREDOXIN 1; PEROXIREDOXIN 5; UNCLASSIFIED DRUG; FRAGILE X MENTAL RETARDATION PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUSION; CELL VACUOLE; CONTROLLED STUDY; CORPUS LUTEUM; CUMULUS OOPHORUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA EXTRACTION; ELECTRON MICROSCOPY; FEMALE; FLOW CYTOMETRY; FRAGILE X PREMUTATION; FRAGILE X SYNDROME; GC RICH SEQUENCE; GENE; GENE DOSAGE; GENE OVEREXPRESSION; GENE SILENCING; GENOTYPE; GRANULOSA CELL; HETEROZYGOSITY; HISTOPATHOLOGY; HOMOZYGOSITY; LITTER SIZE; MFI2 GENE; MITOCHONDRION; MORPHOMETRICS; MOUSE; NONHUMAN; OOCYTE; OOCYTE DEVELOPMENT; OPA1 GENE; OVARY FOLLICLE ATRESIA; OVARY FOLLICLE CELL; OVARY FOLLICLE DEVELOPMENT; OVARY INSUFFICIENCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RNA EXTRACTION; RNA TRANSLATION; SOMATIC CELL; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; CYTOLOGY; DISEASE MODEL; GENETICS; METABOLISM; MUTANT MOUSE STRAIN; OVARY; OVARY FOLLICLE; PATHOLOGY; PREMATURE OVARIAN FAILURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GRANULOSA CELLS; MICE; MICE, MUTANT STRAINS; MITOCHONDRIA; OOCYTES; OVARIAN FOLLICLE; OVARY; PRIMARY OVARIAN INSUFFICIENCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84975127273     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gaw023     Document Type: Article

References (59)

1. Addabbo F, Ratliff B, Park HC, Kuo MC, Ungvari Z, Csiszar A, Ciszar A, Krasnikov B, Krasnikof B, Sodhi K et al. The Krebs cycle and mitochondrial mass are early victims of endothelial dysfunction: proteomic approach. Am J Pathol 2009;174:34-43.
2. Albertini DF, Barrett SL. Oocyte-somatic cell communication. Reprod Suppl2003;61:49-54.
3. Allen EG, Sullivan AK, Marcus M, Small C, Dominguez C, Epstein MP, Charen K, He W, Taylor KC, Sherman SL. Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod2007;22:2142-2152.
4. Ascano M, Mukherjee N, Bandaru P, Miller JB, Nusbaum JD, Corcoran DL, Langlois C, Munschauer M, Dewell S, Hafner M et al. FMRP targets distinct mRNA sequence elements to regulate protein expression. Nature 2012;492:382-386.
5. Behrman HR, Kodaman PH, Preston SL, Gao S. Oxidative stress and the ovary. J Soc Gynecol Investig 2001;8:S40-S42.
6. Bontekoe CJ, Bakker CE, Nieuwenhuizen IM, van der Linde H, Lans H, de Lange D, Hirst MC, Oostra BA. Instability of a (CGG)98 repeat in the Fmr1 promoter. Hum Mol Genet 2001;10:1693-1699.
7. Boucret L,Chao de la Barca JM,Morinière C,DesquiretV, Ferré-L'Hôtellier V, Descamps P, Marcaillou C, Reynier P, Procaccio V, May-Panloup P. Relationship between diminished ovarian reserve and mitochondrial biogenesis in cumulus cells. Hum Reprod 2015;30:1653-1664.
8. Brouwer JR, Mientjes EJ, Bakker CE, Nieuwenhuizen IM, Severijnen LA, Van der LindeHC,Nelson DL, Oostra BA, Willemsen R. ElevatedFmr1mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation. Exp Cell Res 2007;313:244-253.
9. Buijsen RA, Visser JA, Kramer P, Severijnen EA, Gearing M, Charlet-Berguerand N, Sherman SL, Berman RF, Willemsen R, Hukema RK. Presence of inclusions positive for polyglycine containing protein, FMRpolyG, indicates that repeat-associated non-AUG translation plays a role in fragile X-associated primary ovarian insufficiency. Hum Reprod 2015;31:158-168.
10. Carlson JC, Wu XM, Sawada M. Oxygen radicals and the control of ovarian corpus luteum function. Free Radic Biol Med 1993;14:79-84.
11. Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 2003;160:189-200.
12. Chen H, Vermulst M, Wang YE, Chomyn A, Prolla TA, McCaffery JM, Chan DC. Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell 2010; 141:280-289.
13. Coffey SM, Cook K, Tartaglia N, Tassone F, Nguyen DV, Pan R, Bronsky HE, Yuhas J, Borodyanskaya M, Grigsby J et al. Expanded clinical phenotype of women with the FMR1 premutation. Am J Med Genet A 2008; 146A:1009-1016.
14. Czaja MJ, Ding WX, Donohue TM, Friedman SL, Kim JS, Komatsu M, Lemasters JJ, Lemoine A, Lin JD, Ou JhJ et al. Functions of autophagy in normal and diseased liver. Autophagy 2014;9:1131-1158.
15. de Lamirande E, Gagnon C. Reactive oxygen species (ROS) and reproduction. Adv Exp Med Biol 1994;366:185-197.
16. Frank S, Gaume B, Bergmann-Leitner ES, LeitnerWW, Robert EG, Catez F, Smith CL, Youle RJ. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell 2001;1:515-525.
17. Fujioka H, Tandler B, Cohen M, Koontz D, Hoppel CL. Multiple mitochondrial alterations in a case of myopathy. Ultrastruct Pathol2014; 38:204-210.
18. Hagerman R, Hagerman P. Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome. Lancet Neurol 2013;12:786-798.
19. Handa V, Goldwater D, Stiles D, Cam M, Poy G, Kumari D, Usdin K. Long CGG-repeat tracts are toxic to human cells: implications for carriers of Fragile X premutation alleles. FEBS Lett 2005;579:2702-2708.
20. Hoffman GE, LeWW, Entezam A, Otsuka N, Tong ZB, Nelson L, Flaws JA, McDonald JH, Jafar S, Usdin K. Ovarian abnormalities in a mouse model of fragile X primary ovarian insufficiency. J Histochem Cytochem 2012; 60:439-456.
21. Hukema RK, Buijsen RA, Raske C, Severijnen LA, Nieuwenhuizen-Bakker I, Minneboo M, Maas A, de Crom R, Kros JM, Hagerman PJ et al. Induced expression of expanded CGG RNA causes mitochondrial dysfunction in vivo. Cell Cycle 2014;13:2600-2608.
22. Ishihara N, Eura Y, Mihara K. Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity. J Cell Sci 2004; 117:6535-6546.
23. Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature 2004; 428:145-150.
24. Kaplan ES, Cao Z, Hulsizer S, Tassone F, Berman RF, Hagerman PJ, Pessah IN. Early mitochondrial abnormalities in hippocampal neurons cultured from Fmr1 pre-mutation mouse model. J Neurochem 2012a;123:613-621.
25. Kaplan ES, Cao Z, Hulsizer S, Tassone F, Berman RF, Hagerman PJ, Pessah IN. Early mitochondrial abnormalities in hippocampal neurons cultured from Fmr1 pre-mutation mouse model. J Neurochem 2012b;123:613-621.
26. Karuputhula NB, Chattopadhyay R, Chakravarty B, Chaudhury K. Oxidative status in granulosa cells of infertile women undergoing IVF. Syst Biol Reprod Med 2013;59:91-98.
27. Lu C, Lin L, Tan H, Wu H, Sherman SL, Gao F, Jin P, Chen D. Fragile X premutation RNA is sufficient to cause primary ovarian insufficiency in mice. Hum Mol Genet 2012;21:5039-5047.
28. Luderer U. Ovarian toxicity from reactive oxygen species. Vitam Horm 2014; 94:99-127.
29. Luft R, Ikkos D, Palmieri G, Ernster L, Afzelius B. A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study. J Clin Invest 1962;41:1776-1804.
30. McLeod CJ, O'Keefe LV, Richards RI. The pathogenic agent in Drosophila models of 'polyglutamine' diseases. Hum Mol Genet 2005;14:1041-1048.
31. Murray A,Webb J, Grimley S, Conway G, Jacobs P. Studies of FRAXA and FRAXE in women with premature ovarian failure. J Med Genet 1998; 35:637-640.
32. Myers M, Britt KL, Wreford NGM, Ebling FJP, Kerr JB. Methods for quantifying follicular numbers within the mouse ovary. Reproduction 2004;127:569-580.
33. Napoli E, Ross-Inta C,Wong S, Omanska-Klusek A, Barrow C, Iwahashi C, Garcia-Arocena D, Sakaguchi D, Berry-Kravis E, Hager-man R et al. Altered zinc transport disrupts mitochondrial protein processing/import in fragile X-associated tremor/ataxia syndrome. Hum Mol Genet 2011; 20:3079-3092.
34. Oh SY, He F, Krans A, Frazer M, Taylor JP, Paulson HL, Todd PK. RAN translation at CGG repeats induces ubiquitin proteasome system impairment in models of fragile X-associated tremor ataxia syndrome. Hum Mol Genet 2015;24:4317-4326.
35. Otera H, Mihara K. Discovery of the membrane receptor for mitochondrial fission GTPase Drp1. Small GTPases 2011;2:167-172.
36. Pastore LM, Johnson J. The FMR1 gene, infertility, and reproductive decision-making: a review. Front Genet 2014;5:195.
37. Pieretti M, Zhang FP, Fu YH,Warren ST, Oostra BA, CaskeyCT, Nelson DL. Absence of expression of the FMR-1 gene in fragileXsyndrome. Cell 1991; 66:817-822.
38. R Core Team. 2014. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
39. Riva A, Tandler B, Lesnefsky EJ, Conti G, Loffredo F, Vazquez E, Hoppel CL. Structure of cristae in cardiac mitochondria of aged rat. Mech Ageing Dev 2006;127:917-921.
40. Ross-Inta C, Omanska-Klusek A, Wong S, Barrow C, Garcia-Arocena D, Iwahashi C, Berry-Kravis E, Hagerman RJ, Hagerman PJ, Giulivi C. Evidence of mitochondrial dysfunction in fragile X-associated tremor/ ataxia syndrome. Biochem J 2010;429:545-552.
41. Sahin E, Colla S, Liesa M, Moslehi J, Muller FL, Guo M, Cooper M, Kotton D, Fabian AJ, Walkey C et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature2011;470:359-365.
42. Seino T, Saito H, Kaneko T, Takahashi T, Kawachiya S, Kurachi H. Eight-hydroxy-2'-deoxyguanosine in granulosa cells is correlated with the quality of oocytes and embryos in an in vitro fertilization-embryo transfer program. Fertil Steril 2002;77:1184-1190.
43. Sellier C, Rau F, Liu Y, Tassone F, Hukema RK, Gattoni R, Schneider A, Richard S, Willemsen R, Elliott DJ et al. Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients. EMBO J 2010;29:1248-1261.
44. Selier C, Freyermuth F, Tabet R, Tran T, He F, Ruffenach F, Alunni V, Moine H, Thibault C, Page A et al. Sequestration of DROSHA and DGCR8 by expanded CGG RNA repeats alters microRNA processing in fragile X-associated tremor/ataxia syndrome. Cell Rep 2013; 3:869-880.
45. Sutcliffe JS, Nelson DL, Zhang F, Pieretti M, Caskey CT, Saxe D,Warren ST. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet 1992;1:397-400.
46. Tandler B, Hoppel CL. Ultrastructural effects of riboflavin deficiency on rat hepatic mitochondria. Anat Rec 1980;196:183-190.
47. Tassone F, Hagerman RJ, Loesch DZ, Lachiewicz A, Taylor AK, Hagerman PJ. Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA. Am J Med Genet 2000;94:232-236.
48. Tassone F, Beilina A, Carosi C, Albertosi S, Bagni C, Li L, Glover K, Bentley D, Hagerman PJ. Elevated FMR1 mRNA in premutation carriers is due to increased transcription. RNA 2007;13:555-562.
49. Tilly JL. Ovarian follicle counts-not as simple as 1, 2, 3. Reprod Biol Endocrinol 2003;1:11.
50. Todd PK, Oh SY, Krans A, He F, Sellier C, Frazer M, Renoux AJ, Chen KC, Scaglione KM, Basrur V et al. CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome. Neuron 2013;78:440-455.
51. Tokmak A, Yldrm G, Sarkaya E,Çnar M,Bǒgdaycǒ glu N, Ylmaz FM, Ylmaz N. Increased oxidative stress markers may be a promising indicator of risk for primary ovarian insufficiency: a cross-sectional case control study. Rev Bras Ginecol Obstet 2015;37:411-416.
52. Van Blerkom J. Mitochondria in human oogenesis and preimplantation embryogenesis: engines of metabolism, ionic regulation and developmental competence. Reproduction 2004;128:269-280.
53. Van Blerkom J. Mitochondrial function in the human oocyte and embryo and their role in developmental competence. Mitochondrion 2011;11:797-813.
54. Welt CK, Smith PC, Taylor AE. Evidence of early ovarian aging in fragile X premutation carriers. J Clin Endocrinol Metab 2004;89:4569-4574.
55. Wigglesworth K, Lee KB, Emori C, Sugiura K, Eppig JJ. Transcriptomic diversification of developing cumulus and mural granulosa cells in mouse ovarian follicles. Biol Reprod 2015;92:23.
56. Willemsen R, Hoogeveen-Westerveld M, Reis S, Holstege J, Severijnen LA, Nieuwenhuizen IM, Schrier M, van Unen L, Tassone F, Hoogeveen AT et al. The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ ataxia syndrome. Hum Mol Genet 2003;12:949-959.
57. Wojciechowska M, Krzyzosiak WJ. Cellular toxicity of expanded RNA repeats: focus on RNA foci. Hum Mol Genet 2011;20:3811-3821.
58. Zhang Z, Liu L,WuS, Xing D. Drp1, Mff, Fis1, and MiD51 are coordinated to mediate mitochondrial fission during UV irradiation-induced apoptosis. FASEB J 2015;30:466-476.
59. Zorzano A, Claret M. Implications of mitochondrial dynamics on neurodegeneration and on hypothalamic dysfunction. Front Aging Neurosci 2015;7:101.